LIXTW
Closed
Lixte Biotechnology Holdings Inc
0.0233
-0.0053 (-18.53%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.0286
Day's Range: 0.0233 - 0.031
Send
sign up or login to leave a comment!
When Written:
0.069
Lixte Biotechnology Holdings Inc is a clinical-stage drug discovery company that focuses on developing drugs for the treatment of cancer and other serious diseases. The company is based in East Setauket, New York, and was founded in 2005. Lixte Biotechnology is primarily focused on developing drugs that target protein kinases, which are enzymes that play a critical role in the development and progression of cancer. The company's lead drug candidate, LB-100, is currently in clinical trials for the treatment of various types of cancer, including glioblastoma, ovarian cancer, and pancreatic cancer. The company is also developing other drug candidates that target different types of cancer and other diseases. Lixte Biotechnology is a publicly traded company and is listed on the NASDAQ stock exchange under the ticker symbol "LIXT".
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








